Quantitative Dynamic Contrast Enhanced Breast MRI

Completed

Conditions studied: Breast Cancer

In brief

The purpose of this study is to see if dynamic contrast enhanced (DCE) MRI imaging makes it possible to distinguish benign conditions of the breast from malignant tumors and provide better information than can be obtained with regular MRI. DCE MRI uses a new way of collecting and analyzing the images or pictures which provides doctors extra information not available with standard imaging methods. This includes information about the blood vessels of different breast diseases. Pictures produced this way look just like the regular MRI pictures. The DCE MRI adds another imaging sequence (another scan) to the MRI examination ordered by your physician to evaluate your breast lesion, thus increasing the exam time (extra 10 min). The information gained from doing the new test, the DCE MRI, will not be used in your treatment and will not affect the type of care you receive for your breast lesions.

Key facts

Study ID

NCT00582764

Run by

Memorial Sloan Kettering Cancer Center

People needed

116

Starts

2005-09-01

Expected to finish

2015-07-01

Last updated by the study team

2015-07-08

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• · scheduled for breast MRI interventional procedure for a known breast lesion.

You may not qualify if…

• patients who would be normally excluded from undergoing an MRI examination patients with a pacemaker, aneurysm clip or any other condition that would warrant avoidance of a strong magnetic field.
• patients who are unable to cooperate for an MRI, and/or have known reaction to gadolinium contrast agent.

Where it is running

• Memorial Sloan Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.